Screener
Enliven Therapeutics ELVN Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from Enliven Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Enliven Therapeutics’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-211982
FAQ
- What is Enliven Therapeutics's book value per share?
- Enliven Therapeutics (ELVN) reported book value per share of $7.22 in Q1 2026.
- How has Enliven Therapeutics's book value per share changed year-over-year?
- Enliven Therapeutics's book value per share increased by 25.3% year-over-year, from $5.76 to $7.22.
- What is the long-term trend for Enliven Therapeutics's book value per share?
- Over 5 years (2020 to 2025), Enliven Therapeutics's book value per share has grown at a 6.0% compound annual growth rate (CAGR), from $6.06 to $8.11.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.
Ask your AI about Enliven Therapeutics's book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude